Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor
Open Access
- 1 June 2005
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 43 (5) , 808-816
- https://doi.org/10.1016/j.jhep.2005.04.010
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinomaJournal of Hepatology, 2004
- Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1Journal of Hepatology, 2004
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition poreOncogene, 1999
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Effects of pravastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, on two human tumour cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and SimvastatinJournal of Pharmaceutical Sciences, 1991
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979